English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Type I Interferons and Their Receptor Human interferons (IFNs), first recognised for their potent antiviral activity 50 years ago, are a group of naturally occurring cytokines with important immunomodulatory, antiviral, antiangiogenic, antiproliferative and antitumour activities.1 They are classified into three major sub-families based on their biological and physical properties. Type I IFNs include IFN-α, IFN-β, IFN-ε, IFN-κ, IFN-ω, IFN-δ and IFN-τ; among them, IFN-α and IFN-β are the main types of interest, since IFN-ε and IFN-κ are expressed only in the placenta and in keratinocytes and IFN-δ and IFN-τ are not found in humans.2 There are more than 20 different IFN-α genes, of which 13

Increase of IFNAR1 Messenger RNA in Myxovirus-protein-A-induced Multiple Sclerosis Patients to Oppose Loss of Protein Receptor